Atlas Trials

Impact of Proteasome Inhibition on Anti-Donor HLA Antibody Production After Kidney Transplantation

Clinical trial NCT01349595 · TERMINATED

Trial details

NCT number
NCT01349595
Sponsor
Mark Stegall
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Disorder of Transplanted Kidney
Start date
2011-12-01
Primary completion
2015-03-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.